-
21.
公开(公告)号:CO6930310A2
公开(公告)日:2014-04-28
申请号:CO14082286
申请日:2014-04-15
Applicant: UCB PHARMA SA
-
公开(公告)号:AU2012283388A1
公开(公告)日:2014-01-09
申请号:AU2012283388
申请日:2012-07-13
Applicant: UCB PHARMA SA
Inventor: ELLIS MARK , HUMPHREYS DAVID PAUL
Abstract: The present invention provides a recombinant gram-negative bacterial cell comprising an expression vector, comprising a recombinant polynucleotide encoding DsbC and one or more polynucleotides encoding an antibody or an antigen binding fragment thereof specifically binding to CD154.
-
公开(公告)号:CA2865261A1
公开(公告)日:2013-08-29
申请号:CA2865261
申请日:2013-02-22
Applicant: UCB PHARMA SA
Inventor: HUMPHREYS DAVID PAUL , PETERS SHIRLEY JANE
IPC: C07K16/00
Abstract: The present disclosure provides an asymmetric mixed antibody comprising two heavy chains or heavy chain fragments each comprising at least a variable region, a hinge region and a CH1 domain, wherein a first heavy chain or fragment thereof is a class IgG4 and has: a the inter-chain cysteine at position 127, numbered according to the Kabat numbering system, in the CH1 domain is substituted with another amino acid; and b optionally one or more of the amino acids positioned in the upper hinge region is substituted with cysteine, and wherein the second heavy chain or fragment thereof is characterised in that part or all of the chain has a different amino acid sequence to said first heavy chain in at least the region outside the variable region (for example the constant region), formulations comprising the same, therapeutic used of both of the above, and processes for preparing the antibodies and formulation.
-
公开(公告)号:AU2011290581A1
公开(公告)日:2013-04-04
申请号:AU2011290581
申请日:2011-08-19
Applicant: UCB PHARMA SA
Inventor: HUMPHREYS DAVID PAUL , PETERS SHIRLEY JANE , ADAMS RALPH , HEADS JAMES
IPC: C07K16/00 , A61K39/395
Abstract: The present invention provides an antibody of the class IgG4 comprising at least one heavy chain which comprises a C
-
公开(公告)号:SG187677A1
公开(公告)日:2013-03-28
申请号:SG2013007950
申请日:2011-08-19
Applicant: UCB PHARMA SA
Inventor: HUMPHREYS DAVID PAUL , PETERS SHIRLEY JANE , ADAMS RALPH , HEADS JAMES
Abstract: The present invention provides an antibody of the class IgG4 comprising at least one heavy chain which comprises a CH1 domain and a hinge region, wherein in each heavy chain: a. the inter-chain cysteine at position 127, numbered according to the Kabat numbering system, in the CH1 domain is substituted with another amino acid; and b. one or more of the amino acids positioned in the upper hinge region is substituted with cysteine.
-
公开(公告)号:AU2011206584A1
公开(公告)日:2012-07-26
申请号:AU2011206584
申请日:2011-01-13
Applicant: UCB PHARMA SA
Inventor: ELLIS MARK , HUMPHREYS DAVID PAUL
IPC: C12N15/70 , C07K14/245
Abstract: The present invention provides a recombinant gram-negative bacterial cell comprising a mutant spr gene encoding a spr protein having a mutation at one or more amino acids selected from D133, H145, H157, N31, R62, 170, Q73, C94, S95, V98, Q99, R100, L108, Y115, V135, L136, G140, R144 and G147 and wherein the cell has reduced Tsp protein activity compared to a wild-type cell.
-
公开(公告)号:AU2010299640A1
公开(公告)日:2012-04-12
申请号:AU2010299640
申请日:2010-09-23
Applicant: UCB PHARMA SA
Inventor: ELLIS MARK , HUMPHREYS DAVID PAUL
Abstract: A recombinant gram-negative bacterial cell comprising one or more of the following mutated protease genes: a. a mutated Tsp gene, wherein the mutated Tsp gene encodes a Tsp protein having reduced protease activity or is a knockout mutated Tsp gene; b. a mutated ptr gene, wherein the mutated ptr gene encodes a Protease III protein having reduced protease activity or is a knockout mutated ptr gene; and c. a mutated DegP gene encoding a DegP protein having chaperone activity and reduced protease activity; wherein the cell is isogenic to a wild-type bacterial cell except for the mutated Tsp gene and/or mutated ptr gene and/or mutated Deg P gene and optionally a polynucleotide sequence encoding a protein of interest.
-
公开(公告)号:CA3080547A1
公开(公告)日:2012-02-23
申请号:CA3080547
申请日:2011-08-19
Applicant: UCB PHARMA SA
Inventor: ADAMS RALPH , HEADS JAMES , HUMPHREYS DAVID PAUL , PETERS SHIRLEY JANE
IPC: C07K16/00 , A61K39/395 , C12N15/13
Abstract: The present invention provides an antibody of the class IgG4 comprising at least one heavy chain which comprises a CH1 domain and a hinge region, wherein in each heavy chain: a. the inter-chain cysteine at position 127, numbered according to the Kabat numbering system, in the CH1 domain is substituted with another amino acid; and b. one or more of the amino acids positioned in the upper hinge region is substituted with cysteine.
-
公开(公告)号:AT541590T
公开(公告)日:2012-02-15
申请号:AT04743216
申请日:2004-07-01
Applicant: UCB PHARMA SA
Inventor: HUMPHREYS DAVID PAUL , HEYWOOD SAM PHILIP , CARRINGTON BRUCE
Abstract: The present invention provides an antibody Fab or Fab' fragment to which at least one effector molecule is attached characterized in that the heavy chain in the fragment is not covalently bonded to the light chain and both the interchain cysteine of C L and the interchain cysteine of C H 1 have been replaced with another amino acid.
-
公开(公告)号:CA2786336A1
公开(公告)日:2011-07-21
申请号:CA2786336
申请日:2011-01-13
Applicant: UCB PHARMA SA
Inventor: ELLIS MARK , HUMPHREYS DAVID PAUL
IPC: C07K14/245 , C12N15/70
Abstract: The present invention provides a recombinant gram-negative bacterial cell, characterized in that the cell: a. comprises a recombinant polynucleotide encoding DsbC; and b. has reduced Tsp protein activity compared to a wild-type cell.
-
-
-
-
-
-
-
-
-